Drugs / CD34+ hematopoietic progenitor cells
last change Apr 2026 re-read 3 minutes ago

CD34+ hematopoietic progenitor cells

Developed for
acute myeloid leukemia
Investigated by
Antonio Pierini

Trials 1

20272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT07552649 Apr 2026 → Apr 2028 expected acute myeloid leukemia Antonio Pierini Not yet recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CD34+ hematopoietic progenitor cells “Purified CD34+ hematopoietic progenitor cells with Treg/Tcon adoptive immunotherapy in allogeneic cell transplantation from HLA-matched related donor” NCT07552649 ↗